NATURE . COM {}

Matching Content Categories {📚}

• Science
• Education
• Health & Fitness

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 42,555,829 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

Direct Advertisers (10)

Reseller Advertisers (38)

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$536,300 per month
Our estimates place Nature.com's monthly online earnings from display ads at $357,511 to $983,155.

Keywords {🔍}

cells, apoptosis, trailr, trail, cll, article, cell, figure, google, scholar, cas, apoltrail, hgsetr, depsipeptide, caspase, patients, valproate, ngml, hdaci, trailinduced, trailhisle, death, signaling, surface, trailhis, expression, receptor, agonistic, receptors, data, human, preparations, ligand, clinical, tumor, cancer, nature, lymphocytic, mabs, primary, processing, chronic, shown, sensitization, primarily, activity, leukemia, forms, results, lines,

Topics {✒️}

nature portfolio permissions reprints tnf-related apoptosis-inducing ligand privacy policy epstein–barr virus-negative burkitt' nature 364 nature related apoptosis-inducing ligand tumour-necrosis factor superfamily advertising tumour necrosis factor histone deacetylase inhibitors related b-cell malignancies death-inducing signaling complex b-cell prolymphocytic leukemia chronic lymphocytic leukaemia development chronic lymphocytic leukemia isotype-matched control antibody conjugated mouse anti-dr4 anti-trail receptor antibodies social media regulate agonist-specific mechanisms materials media death receptor-induced apoptosis author correspondence expresses primarily trail-r1 adaptor molecule fadd/mort1 tumor cell lines permissions express surface trail-r2 histone deacetylase trail-r1 decreased markedly potentiating trail-induced-apoptosis potentiated trail-induced apoptosis primary tumor signals cell surface trail-r2 temperature-sensitive differential affinity cytotoxic ligand trail trail-r1-selective variants primary tumor cells apo2l/trail signals primarily recombinant apo2l/trail versions apoptosis-inducing ability sensitize tumor cells agonistic trail-r1 ab anti-fas antibody distinct caspase cascades cell death differ trail-r2 increased markedly

Questions {❓}

• Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1
         description:Clinical trials have been initiated with Apo2L/TRAIL (Genentech) and agonistic mAbs to TRAIL receptors, -R1 and -R2 (Human Genome Sciences). The apoptosis-inducing ability of these mAbs and different TRAIL preparations, in the presence or absence of histone deacetylase inhibitors (HDACi), varied markedly against primary chronic lymphocytic leukaemia (CLL) cells and various tumor cell lines, demonstrating an unanticipated preferential apoptotic signaling via either TRAIL-R1 or -R2. Contrary to literature reports that TRAIL-induced apoptosis occurs primarily via signaling through TRAIL-R2, CLL cells, in the presence of HDACi, undergo predominantly TRAIL-R1-mediated apoptosis. Consequently, Apo2L/TRAIL, which signals primarily through TRAIL-R2, is virtually devoid of activity against CLL cells. To maximize therapeutic benefit, it is essential to ascertain whether a primary tumor signals via TRAIL-R1/-R2, prior to initiating therapy. Thus combination of an agonistic TRAIL-R1 Ab and an HDACi, such as the anticonvulsant sodium valproate, could be of value in treating CLL.
         datePublished:2005-04-29T00:00:00Z
         dateModified:2005-04-29T00:00:00Z
         pageStart:773
         pageEnd:782
         sameAs:https://doi.org/10.1038/sj.cdd.4401649
         keywords:
            chronic lymphocytic leukaemia
            tumor necrosis factor-apoptosis inducing ligand
            TRAIL-R1
            histone deacetylase inhibitors
            Life Sciences
            general
            Biochemistry
            Cell Biology
            Stem Cells
            Apoptosis
            Cell Cycle Analysis
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig5_HTML.jpg
         isPartOf:
            name:Cell Death & Differentiation
            issn:
               1476-5403
               1350-9047
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:M MacFarlane
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S Inoue
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S L Kohlhaas
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A Majid
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:N Harper
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:D B J Kennedy
               affiliation:
                     name:University of Leicester, Leicester Royal Infirmary
                     address:
                        name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M J S Dyer
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
                     name:University of Leicester, Leicester Royal Infirmary
                     address:
                        name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:G M Cohen
               affiliation:
                     name:University of Leicester
                     address:
                        name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1
      description:Clinical trials have been initiated with Apo2L/TRAIL (Genentech) and agonistic mAbs to TRAIL receptors, -R1 and -R2 (Human Genome Sciences). The apoptosis-inducing ability of these mAbs and different TRAIL preparations, in the presence or absence of histone deacetylase inhibitors (HDACi), varied markedly against primary chronic lymphocytic leukaemia (CLL) cells and various tumor cell lines, demonstrating an unanticipated preferential apoptotic signaling via either TRAIL-R1 or -R2. Contrary to literature reports that TRAIL-induced apoptosis occurs primarily via signaling through TRAIL-R2, CLL cells, in the presence of HDACi, undergo predominantly TRAIL-R1-mediated apoptosis. Consequently, Apo2L/TRAIL, which signals primarily through TRAIL-R2, is virtually devoid of activity against CLL cells. To maximize therapeutic benefit, it is essential to ascertain whether a primary tumor signals via TRAIL-R1/-R2, prior to initiating therapy. Thus combination of an agonistic TRAIL-R1 Ab and an HDACi, such as the anticonvulsant sodium valproate, could be of value in treating CLL.
      datePublished:2005-04-29T00:00:00Z
      dateModified:2005-04-29T00:00:00Z
      pageStart:773
      pageEnd:782
      sameAs:https://doi.org/10.1038/sj.cdd.4401649
      keywords:
         chronic lymphocytic leukaemia
         tumor necrosis factor-apoptosis inducing ligand
         TRAIL-R1
         histone deacetylase inhibitors
         Life Sciences
         general
         Biochemistry
         Cell Biology
         Stem Cells
         Apoptosis
         Cell Cycle Analysis
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.cdd.4401649/MediaObjects/41418_2005_Article_BF4401649_Fig5_HTML.jpg
      isPartOf:
         name:Cell Death & Differentiation
         issn:
            1476-5403
            1350-9047
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:M MacFarlane
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S Inoue
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S L Kohlhaas
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A Majid
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:N Harper
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:D B J Kennedy
            affiliation:
                  name:University of Leicester, Leicester Royal Infirmary
                  address:
                     name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M J S Dyer
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
                  name:University of Leicester, Leicester Royal Infirmary
                  address:
                     name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:G M Cohen
            affiliation:
                  name:University of Leicester
                  address:
                     name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cell Death & Differentiation
      issn:
         1476-5403
         1350-9047
      volumeNumber:12
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester, Leicester Royal Infirmary
      address:
         name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
      name:University of Leicester, Leicester Royal Infirmary
      address:
         name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
         type:PostalAddress
      name:University of Leicester
      address:
         name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:M MacFarlane
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:S Inoue
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:S L Kohlhaas
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:A Majid
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:N Harper
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      name:D B J Kennedy
      affiliation:
            name:University of Leicester, Leicester Royal Infirmary
            address:
               name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
               type:PostalAddress
            type:Organization
      name:M J S Dyer
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
            name:University of Leicester, Leicester Royal Infirmary
            address:
               name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
               type:PostalAddress
            type:Organization
      name:G M Cohen
      affiliation:
            name:University of Leicester
            address:
               name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK
      name:Department of Hematology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
      name:MRC Toxicology Unit, Hodgkin Building, University of Leicester, Leicester, UK

Social Networks {👍}(1)

• https://twitter.com/cddpress

External Links {🔗}(123)

• What's the profit of http://www.ncbi.nlm.nih.gov/BLAST/?
• Find out how much http://www.ebi.ac.uk/clustalw/ earns monthly
• How much profit does https://doi.org/10.1172%2FJCI6926 generate?
• Income figures for http://scholar.google.com/scholar_lookup?&title=Safety%20and%20antitumor%20activity%20of%20recombinant%20soluble%20Apo2%20ligand&journal=J.%20Clin.%20Invest.&doi=10.1172%2FJCI6926&volume=104&pages=155-162&publication_year=1999&author=Ashkenazi%2CA&author=Pai%2CRC&author=Fong%2CS&author=Leung%2CS&author=Lawrence%2CDA&author=Marsters%2CSA&author=Blackie%2CC&author=Chang%2CL&author=McMurtrey%2CAE&author=Hebert%2CA&author=DeForge%2CL&author=Koumenis%2CIL&author=Lewis%2CD&author=Harris%2CL&author=Bussiere%2CJ&author=Koeppen%2CH&author=Shahrokh%2CZ&author=Schwall%2CRH
• Earnings of https://doi.org/10.1016%2F1074-7613%2895%2990057-8
• What's the income of http://scholar.google.com/scholar_lookup?&title=Identification%20and%20characterization%20of%20a%20new%20member%20of%20the%20TNF%20family%20that%20induces%20apoptosis&journal=Immunity&doi=10.1016%2F1074-7613%2895%2990057-8&volume=3&pages=673-682&publication_year=1995&author=Wiley%2CSR&author=Schooley%2CK&author=Smolak%2CPJ&author=Din%2CWS&author=Huang%2CCP&author=Nicholl%2CJK&author=Sutherland%2CGR&author=Smith%2CTD&author=Rauch%2CC&author=Smith%2CCA&author=Goodwin%2CRG?
• What's the revenue for https://doi.org/10.1074%2Fjbc.271.22.12687?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Induction%20of%20apoptosis%20by%20Apo-2%20ligand%2C%20a%20new%20member%20of%20the%20tumor%20necrosis%20factor%20cytokine%20family&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.271.22.12687&volume=271&pages=12687-12690&publication_year=1996&author=Pitti%2CRM&author=Marsters%2CSA&author=Ruppert%2CS&author=Donahue%2CCJ&author=Moore%2CA&author=Ashkenazi%2CA?
• Learn about the earnings of https://doi.org/10.1038%2F5517
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Tumoricidal%20activity%20of%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20in%20vivo&journal=Nat.%20Med.&doi=10.1038%2F5517&volume=5&pages=157-163&publication_year=1999&author=Walczak%2CH&author=Miller%2CRE&author=Ariail%2CK&author=Gliniak%2CB&author=Griffith%2CTS&author=Kubin%2CM&author=Chin%2CW&author=Jones%2CJ&author=Woodward%2CA&author=Le%2CT&author=Smith%2CC&author=Smolak%2CP&author=Goodwin%2CRG&author=Rauch%2CCT&author=Schuh%2CJC&author=Lynch%2CDH
• Get to know https://doi.org/10.1038%2F35008667's earnings
• How much revenue does http://scholar.google.com/scholar_lookup?&title=TRAIL%20receptor-2%20signals%20apoptosis%20through%20FADD%20and%20caspase-8&journal=Nat.%20Cell%20Biol.&doi=10.1038%2F35008667&volume=2&pages=241-243&publication_year=2000&author=Bodmer%2CJL&author=Holler%2CN&author=Reynard%2CS&author=Vinciguerra%2CP&author=Schneider%2CP&author=Juo%2CP&author=Blenis%2CJ&author=Tschopp%2CJ produce monthly?
• How much revenue does https://doi.org/10.1016%2FS1074-7613%2800%2980212-5 produce monthly?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Apo2L%2FTRAIL-dependent%20recruitment%20of%20endogenous%20FADD%20and%20caspase-8%20to%20death%20receptors%204%20and%205&journal=Immunity&doi=10.1016%2FS1074-7613%2800%2980212-5&volume=12&pages=611-620&publication_year=2000&author=Kischkel%2CFC&author=Lawrence%2CDA&author=Chuntharapai%2CA&author=Schow%2CP&author=Kim%2CKJ&author=Ashkenazi%2CA?
• https://doi.org/10.1016%2FS1074-7613%2800%2980211-3's financial summary
• How much does http://scholar.google.com/scholar_lookup?&title=FADD%2FMORT1%20and%20caspase-8%20are%20recruited%20to%20TRAIL%20receptors%201%20and%202%20and%20are%20essential%20for%20apoptosis%20mediated%20by%20TRAIL%20receptor%202&journal=Immunity&doi=10.1016%2FS1074-7613%2800%2980211-3&volume=12&pages=599-609&publication_year=2000&author=Sprick%2CMR&author=Weigand%2CMA&author=Rieser%2CE&author=Rauch%2CCT&author=Juo%2CP&author=Blenis%2CJ&author=Krammer%2CPH&author=Walczak%2CH rake in every month?
• How much revenue does https://doi.org/10.1006%2Fexcr.2000.4835 bring in?
• http://scholar.google.com/scholar_lookup?&title=Protein%20complexes%20activate%20distinct%20caspase%20cascades%20in%20death%20receptor%20and%20stress-induced%20apoptosis&journal=Exp.%20Cell%20Res.&doi=10.1006%2Fexcr.2000.4835&volume=256&pages=27-33&publication_year=2000&author=Bratton%2CSB&author=MacFarlane%2CM&author=Cain%2CK&author=Cohen%2CGM's total income per month
• How much income does https://doi.org/10.1038%2Fnrc821 have?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Targeting%20death%20and%20decoy%20receptors%20of%20the%20tumour-necrosis%20factor%20superfamily&journal=Nat.%20Rev.%20Cancer&doi=10.1038%2Fnrc821&volume=2&pages=420-430&publication_year=2002&author=Ashkenazi%2CA
• https://doi.org/10.1126%2Fscience.281.5381.1305's total income per month
• Profit of http://scholar.google.com/scholar_lookup?&title=Death%20receptors%3A%20signaling%20and%20modulation&journal=Science&doi=10.1126%2Fscience.281.5381.1305&volume=281&pages=1305-1308&publication_year=1998&author=Ashkenazi%2CA&author=Dixit%2CVM
• Discover the revenue of https://doi.org/10.1038%2Fsj.cdd.4401187
• How much profit is http://scholar.google.com/scholar_lookup?&title=Apo2L%2FTRAIL%20and%20its%20death%20and%20decoy%20receptors&journal=Cell%20Death%20Differ.&doi=10.1038%2Fsj.cdd.4401187&volume=10&pages=66-75&publication_year=2003&author=LeBlanc%2CHN&author=Ashkenazi%2CA making per month?
• How much does https://doi.org/10.1038%2F75045 generate monthly?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Apoptosis%20induced%20in%20normal%20human%20hepatocytes%20by%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand&journal=Nat.%20Med.&doi=10.1038%2F75045&volume=6&pages=564-567&publication_year=2000&author=Jo%2CM&author=Kim%2CTH&author=Seol%2CDW&author=Esplen%2CJE&author=Dorko%2CK&author=Billiar%2CTR&author=Strom%2CSC?
• What's https://doi.org/10.1046%2Fj.1365-2141.2000.02404.x's gross income?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20tumour%20necrosis%20factor%20%28TNF%29-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%20receptors%20and%20sensitivity%20to%20TRAIL-induced%20apoptosis%20in%20primary%20B-cell%20acute%20lymphoblastic%20leukaemia%20cells&journal=Br.%20J.%20Haematol.&doi=10.1046%2Fj.1365-2141.2000.02404.x&volume=111&pages=580-586&publication_year=2000&author=Clodi%2CK&author=Wimmer%2CD&author=Li%2CY&author=Goodwin%2CR&author=Jaeger%2CU&author=Mann%2CG&author=Gadner%2CH&author=Younes%2CA?
• Financial intake of https://doi.org/10.1038%2Fsj.onc.1205853
• How much money does http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20resistance%20to%20TRAIL-induced%20apoptosis%20in%20primary%20B%20cell%20chronic%20lymphocytic%20leukaemia&journal=Oncogene&doi=10.1038%2Fsj.onc.1205853&volume=21&pages=6809-6818&publication_year=2002&author=MacFarlane%2CM&author=Harper%2CN&author=Snowden%2CRT&author=Dyer%2CMJ&author=Barnett%2CGA&author=Pringle%2CJH&author=Cohen%2CGM generate?
• What's the revenue for https://doi.org/10.1046%2Fj.1365-2141.1997.4393250.x?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Activity%20of%20TNF-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%20in%20haematological%20malignancies&journal=Br.%20J.%20Haematol.&doi=10.1046%2Fj.1365-2141.1997.4393250.x&volume=99&pages=618-624&publication_year=1997&author=Snell%2CV&author=Clodi%2CK&author=Zhao%2CS&author=Goodwin%2CR&author=Thomas%2CEK&author=Morris%2CSW&author=Kadin%2CME&author=Cabanillas%2CF&author=Andreeff%2CM&author=Younes%2CA?
• How much revenue does https://doi.org/10.1016%2Fj.drup.2004.03.002 bring in?
• How much does http://scholar.google.com/scholar_lookup?&title=Enhancement%20of%20therapeutic%20potential%20of%20TRAIL%20by%20cancer%20chemotherapy%20and%20irradiation%3A%20mechanisms%20and%20clinical%20implications&journal=Drug%20Resist.%20Update&doi=10.1016%2Fj.drup.2004.03.002&volume=7&pages=139-156&publication_year=2004&author=Shankar%2CS&author=Srivastava%2CRK net monthly?
• Explore the financials of https://doi.org/10.1038%2Fsj.cdd.4401535
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylase%20inhibitors%20potentiate%20TNF-related%20apoptosis-inducing%20ligand%20%28TRAIL%29-induced%20apoptosis%20in%20lymphoid%20malignancies&journal=Cell%20Death%20Differ.&doi=10.1038%2Fsj.cdd.4401535&volume=11&issue=Suppl%202&pages=S193-206&publication_year=2004&author=Inoue%2CS&author=MacFarlane%2CM&author=Harper%2CN&author=Wheat%2CLM&author=Dyer%2CMJ&author=Cohen%2CGM bring in?
• What are the total earnings of https://doi.org/10.1038%2F35106079?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylases%20and%20cancer%3A%20causes%20and%20therapies&journal=Nat.%20Rev.%20Cancer&doi=10.1038%2F35106079&volume=1&pages=194-202&publication_year=2001&author=Marks%2CP&author=Rifkind%2CRA&author=Richon%2CVM&author=Breslow%2CR&author=Miller%2CT&author=Kelly%2CWK
• Profit of https://doi.org/10.1016%2FS1471-4892%2803%2900084-5
• How much does http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylases&journal=Curr.%20Opin.%20Pharmacol.&doi=10.1016%2FS1471-4892%2803%2900084-5&volume=3&pages=344-351&publication_year=2003&author=Marks%2CPA&author=Miller%2CT&author=Richon%2CVM bring in each month?
• How profitable is https://doi.org/10.1074%2Fjbc.M409578200?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=The%20C-terminal%20tails%20of%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%20and%20Fas%20receptors%20have%20opposing%20functions%20in%20Fas-associated%20Death%20Domain%20%28FADD%29%20recruitment%20and%20can%20regulate%20agonist-specific%20mechanisms%20of%20receptor%20activation&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M409578200&volume=279&pages=52479-52486&publication_year=2004&author=Thomas%2CLR&author=Johnson%2CRL&author=Reed%2CJC&author=Thorburn%2CA?
• How much does https://doi.org/10.1074%2Fjbc.272.41.25417 generate monthly?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Identification%20and%20molecular%20cloning%20of%20two%20novel%20receptors%20for%20the%20cytotoxic%20ligand%20TRAIL&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.272.41.25417&volume=272&pages=25417-25420&publication_year=1997&author=MacFarlane%2CM&author=Ahmad%2CM&author=Srinivasula%2CSM&author=Fernandes-Alnemri%2CT&author=Cohen%2CGM&author=Alnemri%2CES
• How much income does https://doi.org/10.1074%2Fjbc.M101287200 have?
• How much does http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylase%20is%20a%20direct%20target%20of%20valproic%20acid%2C%20a%20potent%20anticonvulsant%2C%20mood%20stabilizer%2C%20and%20teratogen&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M101287200&volume=276&pages=36734-36741&publication_year=2001&author=Phiel%2CCJ&author=Zhang%2CF&author=Huang%2CEY&author=Guenther%2CMG&author=Lazar%2CMA&author=Klein%2CPS earn?
• How much does https://doi.org/10.1093%2Femboj%2F20.24.6969 earn?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Valproic%20acid%20defines%20a%20novel%20class%20of%20HDAC%20inhibitors%20inducing%20differentiation%20of%20transformed%20cells&journal=EMBO%20J.&doi=10.1093%2Femboj%2F20.24.6969&volume=20&pages=6969-6978&publication_year=2001&author=Gottlicher%2CM&author=Minucci%2CS&author=Zhu%2CP&author=Kramer%2COH&author=Schimpf%2CA&author=Giavara%2CS&author=Sleeman%2CJP&author=Lo%20Coco%2CF&author=Nervi%2CC&author=Pelicci%2CPG&author=Heinzel%2CT
• How profitable is https://doi.org/10.1083%2Fjcb.148.6.1239?
• How much does http://scholar.google.com/scholar_lookup?&title=Active%20caspases%20and%20cleaved%20cytokeratins%20are%20sequestered%20into%20cytoplasmic%20inclusions%20in%20TRAIL-induced%20apoptosis&journal=J.%20Cell%20Biol.&doi=10.1083%2Fjcb.148.6.1239&volume=148&pages=1239-1254&publication_year=2000&author=MacFarlane%2CM&author=Merrison%2CW&author=Dinsdale%2CD&author=Cohen%2CGM make?
• What's the monthly money flow for https://doi.org/10.1126%2Fscience.282.5393.1497?
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Requirement%20for%20p53%20and%20p21%20to%20sustain%20G2%20arrest%20after%20DNA%20damage&journal=Science&doi=10.1126%2Fscience.282.5393.1497&volume=282&pages=1497-1501&publication_year=1998&author=Bunz%2CF&author=Dutriaux%2CA&author=Lengauer%2CC&author=Waldman%2CT&author=Zhou%2CS&author=Brown%2CJP&author=Sedivy%2CJM&author=Kinzler%2CKW&author=Vogelstein%2CB each month?
• https://doi.org/10.1056%2FNEJM200012283432602's total income per month
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Genomic%20aberrations%20and%20survival%20in%20chronic%20lymphocytic%20leukemia&journal=N.%20Engl.%20J.%20Med.&doi=10.1056%2FNEJM200012283432602&volume=343&pages=1910-1916&publication_year=2000&author=Dohner%2CH&author=Stilgenbauer%2CS&author=Benner%2CA&author=Leupolt%2CE&author=Krober%2CA&author=Bullinger%2CL&author=Dohner%2CK&author=Bentz%2CM&author=Lichter%2CP?
• Revenue of https://doi.org/10.1002%2Fcncr.0680
• How much does http://scholar.google.com/scholar_lookup?&title=Frequency%20and%20type%20of%20serious%20infections%20in%20fludarabine-refractory%20B-cell%20chronic%20lymphocytic%20leukemia%20and%20small%20lymphocytic%20lymphoma%3A%20implications%20for%20clinical%20trials%20in%20this%20patient%20population&journal=Cancer&doi=10.1002%2Fcncr.0680&volume=94&pages=2033-2039&publication_year=2002&author=Perkins%2CJG&author=Flynn%2CJM&author=Howard%2CRS&author=Byrd%2CJC net monthly?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10477713 make?
• Income figures for http://scholar.google.com/scholar_lookup?&title=Unmutated%20Ig%20V%28H%29%20genes%20are%20associated%20with%20a%20more%20aggressive%20form%20of%20chronic%20lymphocytic%20leukemia&journal=Blood&volume=94&pages=1848-1854&publication_year=1999&author=Hamblin%2CTJ&author=Davis%2CZ&author=Gardiner%2CA&author=Oscier%2CDG&author=Stevenson%2CFK
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10477712 net monthly?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Ig%20V%20gene%20mutation%20status%20and%20CD38%20expression%20as%20novel%20prognostic%20indicators%20in%20chronic%20lymphocytic%20leukemia&journal=Blood&volume=94&pages=1840-1847&publication_year=1999&author=Damle%2CRN&author=Wasil%2CT&author=Fais%2CF&author=Ghiotto%2CF&author=Valetto%2CA&author=Allen%2CSL&author=Buchbinder%2CA&author=Budman%2CD&author=Dittmar%2CK&author=Kolitz%2CJ&author=Lichtman%2CSM&author=Schulman%2CP&author=Vinciguerra%2CVP&author=Rai%2CKR&author=Ferrarini%2CM&author=Chiorazzi%2CN?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Molecular%20determinants%20of%20response%20to%20TRAIL%20in%20killing%20of%20normal%20and%20cancer%20cells&journal=Clin.%20Cancer%20Res.&volume=6&pages=335-346&publication_year=2000&author=Kim%2CK&author=Fisher%2CMJ&author=Xu%2CSQ&author=el-Deiry%2CWS?
• https://doi.org/10.1046%2Fj.1365-2141.2003.04699.x's revenue stream
• How much money does http://scholar.google.com/scholar_lookup?&title=Chemical%20sensitization%20and%20regulation%20of%20TRAIL-induced%20apoptosis%20in%20a%20panel%20of%20B-lymphocytic%20leukaemia%20cell%20lines&journal=Br.%20J.%20Haematol.&doi=10.1046%2Fj.1365-2141.2003.04699.x&volume=123&pages=921-932&publication_year=2003&author=Kang%2CJ&author=Kisenge%2CRR&author=Toyoda%2CH&author=Tanaka%2CS&author=Bu%2CJ&author=Azuma%2CE&author=KomadaY%2C make?
• What are the total earnings of https://doi.org/10.1074%2Fjbc.M910438199?
• How much does http://scholar.google.com/scholar_lookup?&title=Temperature-sensitive%20differential%20affinity%20of%20TRAIL%20for%20its%20receptors.%20DR5%20is%20the%20highest%20affinity%20receptor&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M910438199&volume=275&pages=23319-23325&publication_year=2000&author=Truneh%2CA&author=Sharma%2CS&author=Silverman%2CC&author=Khandekar%2CS&author=Reddy%2CMP&author=Deen%2CKC&author=McLaughlin%2CMM&author=Srinivasula%2CSM&author=Livi%2CGP&author=Marshall%2CLA&author=Alnemri%2CES&author=Williams%2CWV&author=Doyle%2CML net monthly?
• How much does https://doi.org/10.1182%2Fblood-2003-12-4333 pull in monthly?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20myelodysplastic%20syndromes%20with%20valproic%20acid%20alone%20or%20in%20combination%20with%20all-trans%20retinoic%20acid&journal=Blood&doi=10.1182%2Fblood-2003-12-4333&volume=104&pages=1266-1269&publication_year=2004&author=Kuendgen%2CA&author=Strupp%2CC&author=Aivado%2CM&author=Bernhardt%2CA&author=Hildebrandt%2CB&author=Haas%2CR&author=Germing%2CU&author=Gattermann%2CN
• What's the financial outcome of https://doi.org/10.1097%2F00062752-200207000-00010?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Histone%20deacetylases%20as%20therapeutic%20targets%20in%20hematologic%20malignancies&journal=Curr.%20Opin.%20Hematol.&doi=10.1097%2F00062752-200207000-00010&volume=9&pages=322-332&publication_year=2002&author=Melnick%2CA&author=Licht%2CJD?
• Get to know what's the income of https://doi.org/10.1074%2Fjbc.M410660200
• How much does http://scholar.google.com/scholar_lookup?&title=Receptor-selective%20mutants%20of%20apoptosis-inducing%20ligand%202L%2Ftumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20reveal%20a%20greater%20contribution%20of%20death%20receptor%20%28DR%29%205%20than%20DR4%20to%20apoptosis%20signaling&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M410660200&volume=280&pages=2205-2212&publication_year=2005&author=Kelley%2CRF&author=Totpal%2CK&author=Lindstrom%2CSH&author=Mathieu%2CM&author=Billeci%2CK&author=Deforge%2CL&author=Pai%2CR&author=Hymowitz%2CSG&author=Ashkenazi%2CA gross monthly?
• Monthly income for https://doi.org/10.1038%2F91000
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Tumoricidal%20activity%20of%20a%20novel%20anti-human%20DR5%20monoclonal%20antibody%20without%20hepatocyte%20cytotoxicity&journal=Nat.%20Med.&doi=10.1038%2F91000&volume=7&pages=954-960&publication_year=2001&author=Ichikawa%2CK&author=Liu%2CW&author=Zhao%2CL&author=Wang%2CZ&author=Liu%2CD&author=Ohtsuka%2CT&author=Zhang%2CH&author=Mountz%2CJD&author=Koopman%2CWJ&author=Kimberly%2CRP&author=Zhou%2CT bring in?
• What's the income of https://doi.org/10.1182%2Fblood.V98.3.795?
• How profitable is http://scholar.google.com/scholar_lookup?&title=TRAIL%2FApo2L%20ligand%20selectively%20induces%20apoptosis%20and%20overcomes%20drug%20resistance%20in%20multiple%20myeloma%3A%20therapeutic%20applications&journal=Blood&doi=10.1182%2Fblood.V98.3.795&volume=98&pages=795-804&publication_year=2001&author=Mitsiades%2CCS&author=Treon%2CSP&author=Mitsiades%2CN&author=Shima%2CY&author=Richardson%2CP&author=Schlossman%2CR&author=Hideshima%2CT&author=Anderson%2CKC?
• How much does https://doi.org/10.1038%2F364806a0 pull in?
• How much does http://scholar.google.com/scholar_lookup?&title=Lethal%20effect%20of%20the%20anti-Fas%20antibody%20in%20mice&journal=Nature&doi=10.1038%2F364806a0&volume=364&pages=806-809&publication_year=1993&author=Ogasawara%2CJ&author=Watanabe-Fukunaga%2CR&author=Adachi%2CM&author=Matsuzawa%2CA&author=Kasugai%2CT&author=Kitamura%2CY&author=Itoh%2CN&author=Suda%2CT&author=Nagata%2CS gross monthly?
• Discover the revenue of https://doi.org/10.1038%2F86397
• How much does http://scholar.google.com/scholar_lookup?&title=Differential%20hepatocyte%20toxicity%20of%20recombinant%20Apo2L%2FTRAIL%20versions&journal=Nat.%20Med.&doi=10.1038%2F86397&volume=7&pages=383-385&publication_year=2001&author=Lawrence%2CD&author=Shahrokh%2CZ&author=Marsters%2CS&author=Achilles%2CK&author=Shih%2CD&author=Mounho%2CB&author=Hillan%2CK&author=Totpal%2CK&author=DeForge%2CL&author=Schow%2CP&author=Hooley%2CJ&author=Sherwood%2CS&author=Pai%2CR&author=Leung%2CS&author=Khan%2CL&author=Gliniak%2CB&author=Bussiere%2CJ&author=Smith%2CCA&author=Strom%2CSS&author=Kelley%2CS&author=Fox%2CJA&author=Thomas%2CD&author=Ashkenazi%2CA make?
• Earnings of https://doi.org/10.1074%2Fjbc.M404541200
• How much profit does http://scholar.google.com/scholar_lookup?&title=Death%20induction%20by%20recombinant%20native%20TRAIL%20and%20its%20prevention%20by%20a%20caspase%209%20inhibitor%20in%20primary%20human%20esophageal%20epithelial%20cells&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M404541200&volume=279&pages=40044-40052&publication_year=2004&author=Kim%2CSH&author=Kim%2CK&author=Kwagh%2CJG&author=Dicker%2CDT&author=Herlyn%2CM&author=Rustgi%2CAK&author=Chen%2CY&author=El-Deiry%2CWS generate?
• What's the revenue for https://doi.org/10.1038%2Fsj.cdd.4401331?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Human%20normal%20hepatocytes%20are%20susceptible%20to%20apoptosis%20signal%20mediated%20by%20both%20TRAIL-R1%20and%20TRAIL-R2&journal=Cell%20Death%20Differ.&doi=10.1038%2Fsj.cdd.4401331&volume=11&pages=203-207&publication_year=2004&author=Mori%2CE&author=Thomas%2CM&author=Motoki%2CK&author=Nakazawa%2CK&author=Tahara%2CT&author=Tomizuka%2CK&author=Ishida%2CI&author=Kataoka%2CS produce monthly?
• How much profit does https://doi.org/10.1158%2F0008-5472.CAN-04-2599 make?
• Income figures for http://scholar.google.com/scholar_lookup?&title=TRAIL%20inhibits%20tumor%20growth%20but%20is%20nontoxic%20to%20human%20hepatocytes%20in%20chimeric%20mice&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-04-2599&volume=64&pages=8502-8506&publication_year=2004&author=Hao%2CC&author=Song%2CJH&author=Hsi%2CB&author=Lewis%2CJ&author=Song%2CDK&author=Petruk%2CKC&author=Tyrrell%2CDL&author=Kneteman%2CNM
• Financial intake of https://doi.org/10.1074%2Fjbc.M109893200
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Bcl-2%20and%20Bcl-xL%20inhibit%20CD95-mediated%20apoptosis%20by%20preventing%20mitochondrial%20release%20of%20Smac%2FDIABLO%20and%20subsequent%20inactivation%20of%20X-linked%20inhibitor-of-apoptosis%20protein&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.M109893200&volume=277&pages=11345-11351&publication_year=2002&author=Sun%2CXM&author=Bratton%2CSB&author=Butterworth%2CM&author=MacFarlane%2CM&author=Cohen%2CGM each month?
• See how much https://doi.org/10.1074%2Fjbc.274.8.5053 makes per month
• What's the profit of http://scholar.google.com/scholar_lookup?&title=Distinct%20caspase%20cascades%20are%20initiated%20in%20receptor-mediated%20and%20chemical-induced%20apoptosis&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.274.8.5053&volume=274&pages=5053-5060&publication_year=1999&author=Sun%2CXM&author=MacFarlane%2CM&author=Zhuang%2CJ&author=Wolf%2CBB&author=Green%2CDR&author=Cohen%2CGM?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9058723 income
• http://scholar.google.com/scholar_lookup?&title=p53%20abnormalities%20in%20B-cell%20prolymphocytic%20leukemia&journal=Blood&volume=89&pages=2015-2023&publication_year=1997&author=Lens%2CD&author=De%20Schouwer%2CPJ&author=Hamoudi%2CRA&author=Abdul-Rauf%2CM&author=Farahat%2CN&author=Matutes%2CE&author=Crook%2CT&author=Dyer%2CMJ&author=Catovsky%2CD's revenue stream
• What are the total earnings of https://doi.org/10.1038%2Fsj.thj.6200325?
• How profitable is http://scholar.google.com/scholar_lookup?&title=Characterisation%20of%20TP53%20abnormalities%20in%20chronic%20lymphocytic%20leukaemia&journal=Hematol.%20J.&doi=10.1038%2Fsj.thj.6200325&volume=5&pages=47-54&publication_year=2004&author=Thornton%2CPD&author=Gruszka-Westwood%2CAM&author=Hamoudi%2CRA&author=Atkinson%2CS&author=Kaczmarek%2CP&author=Morilla%2CRM&author=Hilditch%2CBL&author=A%27Hern%2CR&author=Matutes%2CE&author=Catovsky%2CD?
• https://doi.org/10.1038%2Fsj.leu.2403202's financial summary
• How much does http://scholar.google.com/scholar_lookup?&title=Design%20and%20standardization%20of%20PCR%20primers%20and%20protocols%20for%20detection%20of%20clonal%20immunoglobulin%20and%20T-cell%20receptor%20gene%20recombinations%20in%20suspect%20lymphoproliferations%3A%20report%20of%20the%20BIOMED-2%20Concerted%20Action%20BMH4-CT98-3936&journal=Leukemia&doi=10.1038%2Fsj.leu.2403202&volume=17&pages=2257-2317&publication_year=2003&author=van%20Dongen%2CJJ&author=Langerak%2CAW&author=Bruggemann%2CM&author=Evans%2CPA&author=Hummel%2CM&author=Lavender%2CFL&author=Delabesse%2CE&author=Davi%2CF&author=Schuuring%2CE&author=Garcia-Sanz%2CR&author=van%20Krieken%2CJH&author=Droese%2CJ&author=Gonzalez%2CD&author=Bastard%2CC&author=White%2CHE&author=Spaargaren%2CM&author=Gonzalez%2CM&author=Parreira%2CA&author=Smith%2CJL&author=Morgan%2CGJ&author=Kneba%2CM&author=Macintyre%2CEA pull in monthly?
• How much income does https://citation-needed.springer.com/v2/references/10.1038/sj.cdd.4401649?format=refman&flavour=references have?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20MacFarlane net monthly?
• Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20MacFarlane%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20Inoue earn?
• What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20Inoue%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20L%20Kohlhaas bring in each month?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20L%20Kohlhaas%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
• How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A%20Majid?
• Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A%20Majid%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=N%20Harper
• Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22N%20Harper%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
• Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D%20B%20J%20Kennedy
• Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D%20B%20J%20Kennedy%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20J%20S%20Dyer generate?
• Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20J%20S%20Dyer%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=G%20M%20Cohen?
• Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22G%20M%20Cohen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Profit of https://s100.copyright.com/AppDispatchServlet?title=Chronic%20lymphocytic%20leukemic%20cells%20exhibit%20apoptotic%20signaling%20via%20TRAIL-R1&author=M%20MacFarlane%20et%20al&contentID=10.1038%2Fsj.cdd.4401649©right=Springer%20Nature%20Limited&publication=1350-9047&publicationDate=2005-04-29&publisherName=SpringerNature&orderBeanReset=true
• What's the financial intake of https://citation-needed.springer.com/v2/references/10.1038/sj.cdd.4401649?format=refman&flavour=citation?
• Learn how profitable https://doi.org/10.1007/s12032-023-02276-3 is on a monthly basis
• How much revenue does https://doi.org/10.1038/s41375-023-02035-3 generate?
• Profit of https://doi.org/10.1038/s41418-022-01059-z
• How much profit is https://doi.org/10.1038/cddis.2017.423 making per month?
• Income figures for https://doi.org/10.1038/cdd.2015.174
• What's the monthly income of https://www.protocols.io/?
• What's the revenue for https://www.natureindex.com/?
• How much profit is http://www.naturechina.com making per month?
• Revenue of https://www.natureasia.com/ja-jp

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Prism.js
• Zoom.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk

CDN Services {📦}

• Crossref